Variant report
Variant | esv1843214 |
---|---|
Chromosome Location | chr12:86673989-86703959 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566551901 | chr12:86676625-86676626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541440447 | chr12:86676660-86676661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146273766 | chr12:86676679-86676680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530438703 | chr12:86676691-86676692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183387293 | chr12:86676710-86676711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565237608 | chr12:86676714-86676715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34649355 | chr12:86676763-86676764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs148049148 | chr12:86676765-86676766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564191989 | chr12:86676798-86676799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547624866 | chr12:86676886-86676887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10745408 | chr12:86676912-86676913 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs141846671 | chr12:86676926-86676927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187335551 | chr12:86676937-86676938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570005763 | chr12:86676956-86676957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537054557 | chr12:86676969-86676970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs35691835 | chr12:86676971-86676972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543963810 | chr12:86676995-86676996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558850588 | chr12:86677011-86677012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191699127 | chr12:86677016-86677017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183913753 | chr12:86677019-86677020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186653437 | chr12:86677065-86677066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574570409 | chr12:86677113-86677114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs193118678 | chr12:86677167-86677168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556800161 | chr12:86677201-86677202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs150606903 | chr12:86677236-86677237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185486745 | chr12:86677237-86677238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565227910 | chr12:86677317-86677318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532714209 | chr12:86677392-86677393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139808707 | chr12:86677394-86677395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559553832 | chr12:86677397-86677398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530254381 | chr12:86677433-86677434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561050069 | chr12:86677438-86677439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548619062 | chr12:86677485-86677486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs370475333 | chr12:86677492-86677493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373065808 | chr12:86677509-86677510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570061017 | chr12:86677539-86677540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530924591 | chr12:86677541-86677542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552653871 | chr12:86677566-86677567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12309297 | chr12:86677570-86677571 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs534952596 | chr12:86677731-86677732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs553322266 | chr12:86677771-86677772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568216160 | chr12:86677779-86677780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535292895 | chr12:86677862-86677863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556973820 | chr12:86677937-86677938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575282249 | chr12:86677997-86677998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545391329 | chr12:86678071-86678072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537673835 | chr12:86678086-86678087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557359047 | chr12:86678094-86678095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143581923 | chr12:86678110-86678111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373189938 | chr12:86678111-86678112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:86676600-86680200 | Enhancers | Fetal Heart | heart |
2 | chr12:86677400-86677800 | Enhancers | Rectal Smooth Muscle | rectum |
3 | chr12:86680200-86684600 | Weak transcription | Fetal Heart | heart |
4 | chr12:86684600-86685200 | Enhancers | Fetal Heart | heart |
5 | chr12:86685400-86685600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr12:86685600-86686400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr12:86686400-86687000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr12:86687000-86687600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr12:86687600-86688400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr12:86688400-86689200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr12:86690000-86690600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr12:86690600-86698200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr12:86690800-86692600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr12:86692600-86693800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr12:86693800-86694600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr12:86694800-86695400 | Enhancers | Fetal Lung | lung |